Health Robotics to Showcase CytoCare at ISOPP (May 2010) and Charles University' General Faculty Hospital of Prague

BOZEN, Sud-Tirol, Italy, April 26, 2010 - Health Robotics today announced the upcoming cooperation with the
International Society of Oncology Pharmacy Practitioners (ISOPP), B|Braun
Melsungen, and the General Faculty Hospital of Prague to host ISOPP delegates
at its bi-annual congress to witness live demonstrations of CytoCare in an
Oncology patient setting. CytoCare is the only robot in the world proven to
compound hazardous sterile I.V. Admixtures. ISOPP 2010 delegates may reserve
attendance to this invitation-only event (space limited) at
www.isopp2010.com/en/health-robotics.

CytoCare directly addresses the challenges of Oncology Pharmacy in the
21st Century, as it has globally set the gold standard of automatically
handling the complex and dangerous tasks associated with hazardous CSP
(Compounded Sterile Preparations), increasing quality of care, improving
patient safety, and decreasing costs, with hospital pharmacy Installations in
the United States of America, United Kingdom, Australia, Japan, Malaysia,
Taiwan, Germany, Italy, Belgium, Turkey, Saudi Arabia, Denmark, and Czech
Republic.

"As we are now approaching 60 global installations of CytoCare, it is
indeed a pleasure to share with global ISOPP 2010 delegates the patient and
pharmacy safety benefits that academic medical centers such as Charles
University's General Faculty Hospital have derived from CytoCare over the
last 3 years, especially in contrast with the hype spread by our competitors
who after more than 20 years of unsubstantiated announcements[1,2] have yet
to even attempt to install a single robot in a hospital pharmacy for
chemotherapy use anywhere in the world" stated Werner Rainer, Health
Robotics' CEO.

ISOPP 2010 delegates are also invited to visit Health Robotics' booth
(F04) at the ISOPP Congress May 5th through May 8th, 2010 and witness
presentations and demonstrations of i.v.STATION (robot for adjuvant
therapies), OMM (Oncology Medication Management electronic medical record),
and i.v.SOFT Assist (workflow engine for manual compounding of chemotherapy
IV Admixtures), while Health Robotics' product specialists, European-based
staff, and senior management will be available to answer delegates'
questions.

About Health Robotics:

Health Robotics is the undisputed global leading supplier of
life-critical intra-venous medication robots, providing healthcare facilities
in 5 continents with robotics technology and software automation solutions
deployed utilizing virtual high-availability technology. Its world-leading
solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs],
i.v.SOFT(TM) [workflow engine for manual compounding, powered by
MEDarchiver], and TPNstation(TM) [totally-automated parenteral nutrition]
have and will greatly contribute to ease hospitals' growing pressures to
improve patient safety, increase throughput and contain costs. Through the
effective and efficient production of sterile, accurate, tamper-evident and
ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate
life-threatening drug-exchange errors, decrease other therapy oversights and
sterility risks, work more efficiently, reduce waste and controlled
substances' diversion, and diminish the gap between rising patient
volume/acuity and scarce nursing and pharmacy staff. For more information,
please visit www.health-robotics.com

———————————

[1] www.intelligenthospitals.com/news-pr-2006-06-26.html

[2] Am J Hosp Pharm 46(11): 2286-93 1989

    For additional information, please contact:
    Health Robotics S.r.l.
    Claudia Flaim
    Marketing Coordinator
    Italy: +39-0471-200-372
    flaim@health-robotics.com

For additional information, please contact: Health Robotics S.r.l., Claudia Flaim, Marketing Coordinator, Italy: +39-0471-200-372, flaim at health-robotics.com